Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer

Clinical trial NCT05113537 · RECRUITING

Trial details

NCT number: NCT05113537
Sponsor: Vadim S Koshkin
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Castration-Resistant Prostate Carcinoma Metastatic Prostate Adenocarcinoma Stage IV Prostate Cancer AJCC v8 Stage IVA Prostate Cancer AJCC v8 Stage IVB Prostate Cancer AJCC v8 Metastatic Castration-resistant Prostate Carcinoma Metastatic Castration-resistant Prostate Cancer

Start date: 2022-07-08
Primary completion: 2027-05-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.